Of particular interest, Lu et al reported that poorly surviving non-small cell lung cancer (NSCLC) patients had high Bik expression and compensatory increase in anti-apoptotic protein Bcl-2 led to tumor adaptation [14, 42]. This evidence concerns the gene BCL2 and non-small cell lung carcinoma.